Health

Started by a patient, HealthTree lets blood cancer patients look for clinical trials and treatment options, as well as share their data with researchers.

Anti-fluoridation activists gain powerful allies in Robert F. Kennedy Jr. and a court win against the EPA, to the dismay of public health leaders.

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

A Super Bowl ad for compounded versions of the popular brand name weight-loss drugs has caused controversy. Should weight-loss drugs be for everyone?

A National Institutes of Health memo on Feb. 7 said certain grant funds to universities and research institutions would be capped starting Monday.

In the U.S., bird flu headlines have focused on an unprecedented number of American cases and the impact of the virus on dairy cows and on poultry.

Pa. officials and Prospect Medical Holdings have reached a preliminary agreement to have FTI Consulting temporarily manage the four-hospital system in Delaware County.

Some early session bills in the Pennsylvania legislature align with Gov. Josh Shapiro’s health spending priorities and prepare for possible changes under Trump.

From heart attacks to broken bones, doctors weigh in on how to avoid common health emergencies linked to the big game.

An alarming study on black plastic had a major math error. But it reveals bigger questions that have yet to be addressed.

Prospect Medical Holdings did not identify which parties would be a part of the consortium looking to take over the distressed Crozer Health system in Delaware County.

A look at the potentially harmful things we’re exposed to and how they affect us.

The new pilot program hopes to give veterans a creative outlet to express themselves and find purpose after leaving the military.

A Norfolk Southern train derailment in East Palestine, Ohio, spilled chemicals, sickening residents. Now researchers are tracking the long-term health effects.

Pennsylvania insurance officials say premium costs could rise, on average, by 82% with the loss of boosted tax credits in 2026.